Do Non-steroidal Anti-inflammatory Drugs or Smoking Predispose to Helicobacter Pylori Infection?

Overview

Journal Postgrad Med J

Publisher Oxford University Press

Specialty General Medicine

Date 1990 Sep 1

PMID 2235801

Citations 3

Authors

D G Maxton

E D Srivastava

P J Whorwell

D M Jones

Affiliations

Soon will be listed here.

Abstract

Susceptibility to Helicobacter pylori infection is a poorly understood phenomenon. This study was undertaken to establish whether either smoking or chronic non-steroidal anti-inflammatory drug (NSAID) consumption might in some way predispose to H. pylori infection and hence lead to peptic ulceration. Serological evidence of H. pylori infection was assessed in 100 consecutive subjects receiving NSAIDs without any evidence of gastrointestinal upset and 100 matched controls. All subjects had a full assessment of their smoking habits. Sixty-three per cent of patients taking NSAIDs compared to 51% of controls had evidence of H. pylori infection (NS). Smoking habit also had no effect on H. pylori colonization. The ulcerogenic potential of NSAIDs and smoking does not appear to be mediated via a prediposition to H. pylori infection.

Citing Articles

Relation of Helicobacter pylori infection and lifestyle to the risk of chronic atrophic gastritis: a cross-sectional study in Japan.

Shibata K, Moriyama M, Fukushima T, Une H, Miyazaki M, Yamaguchi N J Epidemiol. 2002; 12(2):105-11.

PMID: 12033520 PMC: 10468346. DOI: 10.2188/jea.12.105.

Lifestyle and anti-Helicobacter pylori immunoglobulin G antibody among outpatients.

Hamajima N, Inoue M, Tajima K, Tominaga S, Matsuura A, Kobayashi S Jpn J Cancer Res. 1998; 88(11):1038-43.

PMID: 9439678 PMC: 5921320. DOI: 10.1111/j.1349-7006.1997.tb00327.x.

Optimizing acid suppression for treatment of acid-related diseases.

Hunt R, Cederberg C, Dent J, Halter F, Howden C, Marks I Dig Dis Sci. 1995; 40(2 Suppl):24S-49S.

PMID: 7859582 DOI: 10.1007/BF02214870.

References

Lanza F, Royer Jr G, Nelson R, Chen T, Seckman C, Rack M . The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study. Dig Dis Sci. 1979; 24(11):823-8. DOI: 10.1007/BF01324896. View

Hawkey C . Non-steroidal anti-inflammatory drugs and the gastric mucosa: mechanisms of damage and protection. Aliment Pharmacol Ther. 1988; 2 Suppl 1:57-64. DOI: 10.1111/j.1365-2036.1988.tb00765.x. View

Marshall B, McGechie D, Rogers P, Glancy R . Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust. 1985; 142(8):439-44. DOI: 10.5694/j.1326-5377.1985.tb113444.x. View

McCready D, Clark L, COHEN M . Cigarette smoking reduces human gastric luminal prostaglandin E2. Gut. 1985; 26(11):1192-6. PMC: 1432902. DOI: 10.1136/gut.26.11.1192. View

Massarrat S, Enschai F, Pittner P . Increased gastric secretory capacity in smokers without gastrointestinal lesions. Gut. 1986; 27(4):433-9. PMC: 1433391. DOI: 10.1136/gut.27.4.433. View

Goodwin C, Armstrong J, Marshall B . Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol. 1986; 39(4):353-65. PMC: 499829. DOI: 10.1136/jcp.39.4.353. View

Rathbone B, Wyatt J, Heatley R . Campylobacter pyloridis--a new factor in peptic ulcer disease?. Gut. 1986; 27(6):635-41. PMC: 1433327. DOI: 10.1136/gut.27.6.635. View

Ainley C, Forgacs I, Keeling P, Thompson R . Outpatient endoscopic survey of smoking and peptic ulcer. Gut. 1986; 27(6):648-51. PMC: 1433314. DOI: 10.1136/gut.27.6.648. View

Jones D, Eldridge J, Fox A, Sethi P, Whorwell P . Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis")--clinical correlations and distribution in the normal population. J Med Microbiol. 1986; 22(1):57-62. DOI: 10.1099/00222615-22-1-57. View

10.

Graham D, KLEIN P . Campylobacter pyloridis gastritis: the past, the present, and speculations about the future. Am J Gastroenterol. 1987; 82(4):283-6. View

11.

Niemela S, Karttunen T, Lehtola J . Campylobacter-like organisms in patients with gastric ulcer. Scand J Gastroenterol. 1987; 22(4):487-90. DOI: 10.3109/00365528708991495. View

12.

Bartlett J . Campylobacter pylori: fact or fancy?. Gastroenterology. 1988; 94(1):229-32. DOI: 10.1016/0016-5085(88)90634-8. View

13.

Skander M, Ryan F . Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly. BMJ. 1988; 297(6652):833-4. PMC: 1834614. DOI: 10.1136/bmj.297.6652.833. View

14.

Loffeld R, Stobberingh E, Flendrig J, van Spreeuwel J, Arends J . Diagnostic value of an immunoassay to detect anti Campylobacter pylori antibodies in non-ulcer dyspepsia. Lancet. 1989; 1(8648):1182-5. DOI: 10.1016/s0140-6736(89)92761-x. View

15.

Collier D, Pain J . Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut. 1985; 26(4):359-63. PMC: 1432521. DOI: 10.1136/gut.26.4.359. View